CT-GRAMERCY-FUNDS-MGMT
Gramercy Funds Management LLC (“Gramercy”), a $6 billion, global emerging markets investment manager, today announced that Hamad Almudhaf has joined the firm in a newly created role, Head of International Capital Markets. Mr. Almudhaf will be responsible for the design and implementation of Gramercy’s international expansion strategy to further enhance the firm’s high quality investor relationships outside of the U.S. He will also have a principal responsibility for the continued development of Gramercy’s international, commercial and capital formation strategy.
“We are thrilled to have Hamad join the Gramercy team in this critically important new role,” said Robert Koenigsberger, Managing Partner and Chief Investment Officer of Gramercy. “Over the last 25 years, Gramercy has successfully established the firm as a prominent global emerging markets investment management company. Hamad’s proven track record of success will further advance our leading position in emerging markets and private credit, and ensure we deliver on our core mission while providing clients with a better approach to emerging markets.”
“We are delighted that Hamad is joining Gramercy,” said Mohamed El-Erian, Chair of Gramercy. “His expertise, experience and accomplishments are not just important supplements to the firm’s resources but also enablers of its further success. We look forward to having him on our team.”
Mr. Almudhaf has over fifteen years of financial markets experience in investment banking and international capital markets and has established a diverse set of important global investor relationships. More recently, Mr. Almudhaf has worked closely with the Gramercy investment team, sourcing and structuring unique investment opportunities while in his senior role at J.P. Morgan’s fixed income franchise in New York City. Prior to J.P. Morgan, Mr. Almudhaf began his investment banking career with Itaú Unibanco, specializing in fixed income credit markets and special situations investments in Latin America. In his new capacity, Mr. Almudhaf will be based in Gramercy’s headquarters in Greenwich, Connecticut and responsible for shaping the firm’s international goals and objectives for growth and expansion.
“We are pleased to announce that Hamad has joined Gramercy,” said Tom Humphrey, President and Senior Partner of Gramercy. “Hamad is extremely well regarded and an experienced global markets professional. His technical expertise, cross-regional experience, and commercial skills will be immediately additive for Gramercy worldwide.”
“I have been working closely with the Gramercy team for many years,” said Mr. Almudhaf. “I am excited to join a team of highly respected, skilled and dedicated global emerging markets professionals. Gramercy’s rigorous investment process creates unique opportunities for clients to deploy capital and I’m looking forward to originating high quality investment solutions across international capital markets.”
Mr. Almudhaf graduated Magna Cum Laude from the Wharton School of the University of Pennsylvania, holding a Bachelor of Science degree in Economics with a triple Concentration in Finance, Strategic Management and Legal Studies & Business Ethics. Mr. Almudhaf is a CFA® charterholder.
About Gramercy:
Gramercy is a global emerging markets investment manager based in Greenwich, Connecticut with offices in London, Buenos Aires, Miami, West Palm Beach and Mexico City, and dedicated lending platforms in Mexico, Turkey, Peru, Pan-Africa, Brazil, and Colombia. The $6-plus billion firm, founded in 1998, seeks to provide investors with a better approach to emerging markets, delivering attractive risk-adjusted returns supported by a transparent and robust institutional platform. Gramercy offers alternative and long-only strategies across emerging markets asset classes, including multi-asset, private credit, public credit, and special situations. Gramercy’s mission is to positively impact the well-being of our clients, portfolio investments and team members. Gramercy is a Registered Investment Adviser with the US Securities and Exchange Commission (SEC), a Signatory of the Principles for Responsible Investment (PRI), a Signatory to the Net Zero Asset Managers initiative (NZAMI) and a Supporter of the Task Force on Climate-Related Financial Disclosures (TCFD). Gramercy Ltd, an affiliate, is registered with the UK Financial Conduct Authority (FCA). www.gramercy.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240319963926/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
LTIMindtree Launches ‘BlueVerse’ — An AI Ecosystem that will Define the Enterprise of the Future19.6.2025 11:30:00 CEST | Press release
LTIMindtree [NSE: LTIM, BSE: 540005], a global technology consulting and digital solutions company, has announced the launch of a new business unit and suite of AI services and solutions: BlueVerse. Designed as a complete AI ecosystem, it helps enterprises accelerate their AI concept-to-value journey. This ecosystem is a universe of components that enterprises need to elevate business operations, achieve breakthrough productivity, and create transformational customer experiences. BlueVerse Marketplace currently has over 300 industry and function-specific agents and ensures seamless interoperability and a growing connector ecosystem. It is underpinned by responsible AI governance, delivering enterprise-grade trust and scalability. BlueVerse Productized Services utilize repeatable frameworks, accelerators, and industry-specific solution kits. At launch, BlueVerse will offer pre-built solutions for Marketing Services and Contact Center as a Service (CCaaS). With Marketing Services busines
KIKO Milano Partners with Logistics Reply to Accelerate E-Commerce Delivery in the UK Market19.6.2025 10:00:00 CEST | Press release
Logistics Reply, the Reply group company specialising in innovative supply chain solutions has partnered with KIKO Milano, the global cosmetics brand renowned for its cutting edge, high-quality beauty products, to transform its e-commerce operations in the UK. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250619841029/en/ This partnership represents a strategic milestone in KIKO’s broader digital transformation journey and reinforces its commitment to operational excellence and an exceptional customer experience. With rapid growth in the UK market and a rising demand for online shopping and fast home delivery, KIKO recognized the need to evolve its supply chain operations. To meet these challenges, KIKO opened a new dark store in London and selected Logistics Reply with its LEA Reply™ Warehouse Management System (WMS) to build a more scalable and agile logistics infrastructure. A dark store is a retail distribution centre t
Chiesi Global Rare Diseases Awards Research Grants to Advance Innovation in Lysosomal Diseases19.6.2025 09:35:00 CEST | Press release
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative solutions for people living with rare diseases, today announced the recipients of its "Find For Rare" research grant program. The independently assessed, expert-led research grant initiative aims to improve patient care and management by recognising innovative research in three lysosomal diseases: Fabry disease, alpha-mannosidosis, and cystinosis. The selected projects demonstrated significant potential to address unmet needs within these rare communities. The recipients include: Fabry disease: Mitra Tavakoli, University of Exeter, Exeter, UK, for her project "FAB-PAIN: Precise phenotyping of neuropathy using a range of novel biomarkers in Fabry Disease” Project overview: This project aims to explore a range of novel biomarkers to better understand the pain pathways and its pathophysiology in Fabry disease. The findings may lead to the development of a range of new neuropathic biomarkers,
Brenus Pharma and InSphero Have Developed 3D Tumor Spheroids Mimicking in vivo Human Colorectal Cancer Conditions and Confirming STC-1010’s Efficacy19.6.2025 09:15:00 CEST | Press release
Presented at EACR 2025, promising results show the impact of Brenus Pharma and InSphero’s collaboration in advancing translational immunotherapy through scalable 3D tumor models. Brenus Pharma, a French biotech developing next-generation first-in-class immunotherapies, and InSphero, a Swiss leader in 3D cell-based assay technologies, presented promising data at the European Association for Cancer Research 2025 annual congress. These data confirm the use of 3D tumor spheroids for potency testing of STC-1010, Brenus’ lead candidate for colorectal cancer. Funded through the EUROSTARS program, the collaboration led to vitrified 3D colorectal cancer spheroids using tumor cell lines co-cultured with fibroblasts. The vitrification method preserves morphology, stromal integrity, and viability after thawing, enabling realistic evaluation of STC-1010’s therapeutic potential under conditions mimicking in vivo human tumors. Previous studies showed that STC-1010 antigens were effectively processed
Textron Aviation Defense and Thai Aviation Industries Sign Agreement to Support Royal Thai Air Force19.6.2025 08:30:00 CEST | Press release
During the Paris Air Show, Textron Aviation Defense LLC., a Textron Inc. (NYSE: TXT) company, and Thai Aviation Industries Co., Ltd. signed a Memorandum of Agreement to work together on a sustainment program for the Royal Thai Air Force (RTAF). This program will support RTAF's fleets of Beechcraft T-6TH and AT-6TH aircraft. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250618711147/en/ Textron Aviation Defense LLC. and Thai Aviation Industries Co., Ltd. sign a Memorandum of Agreement to sustain Beechcraft T-6TH trainer and AT-6TH light attack aircraft for the Royal Thai Air Force (RTAF) The Beechcraft T-6TH trainer and AT-6TH light attack aircraft are designed and manufactured by Textron Aviation Defense LLC., a wholly owned subsidiary of Textron Aviation Inc. Textron Aviation Defense, based in Wichita, Kansas, USA, is the original equipment manufacturer (OEM) for these aircraft. Thai Aviation Industries, located in Bangkok
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom